MELANIE MYERS: Open Payments
NPI 1841616604 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,298 in 60 payments from 14 companies in 2025. Trend: 2023 $2,043 · 2024 $2,282 · 2025 $1,298
Food & beverage: $1,213Education: $85
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $247 |
| GENZYME CORPORATION | 4 | $207 |
| Lilly USA, LLC | 11 | $179 |
| LEO Pharma Inc. | 7 | $153 |
| Regeneron Healthcare Solutions, Inc. | 7 | $148 |
| ABBVIE INC. | 5 | $91 |
| PFIZER INC. | 5 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| UCB, Inc. | 2 | $35 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
Products named: DUPIXENT, ILUMYA, TALTZ, ADBRY, CIBINQO, COSENTYX, SKYRIZI, RINVOQ.
Industry payments across AR — which companies pay providers there.
